Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)
Recruiting now
Conditions studied: Follow-up, Education, Mobile Health
In brief
This trial has to aim to evaluate an innovative, in-house developed mobile application supporting patients in their home environment by actively involving them in different aspects of their condition and treatment. The usability, long-term adherence and patient satisfaction will be studied in patients with atrial fibrillation (AF) and/or heart failure (HF).
Key facts
- Study ID
- NCT05951088
- Run by
- University Hospital, Antwerp
- People needed
- 200
- Starts
- 2023-05-23
- Expected to finish
- 2026-05-30
- Last updated by the study team
- 2026-05-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years,
- Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records,
- Patients who are capable of signing the informed consent.
You may not qualify if…
- Not able to speak and read Dutch,
- Cognitive impaired (e.g. severe dementia),
- No smartphone or tablet available.
Where it is running
- University Hospital Antwerp — Edegem, Antwerp, Belgium (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.